Precipio, Inc. (PRPO)
US Markets · Healthcare · Medical - Diagnostics & Research
$22.10
-2.34%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$43.6M
About Precipio, Inc.
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers HemeScreen, a suite of robust genetic diagnostic panels; and IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.